Cargando…

What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?

BACKGROUND: The optimal number of neoadjuvant chemotherapy (NAC) cycles for resectable colorectal liver oligometastases (CLOM) remains unclear. The aim of this study was to investigate the optimal number of NAC cycles. METHODS: One hundred twenty-nine consecutive patients were included in this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qichen, Li, Xingchen, Zhao, Jianjun, Bi, Xinyu, Li, Zhiyu, Huang, Zhen, Zhang, Yefan, Zhou, Jianguo, Zhao, Hong, Cai, Jianqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859783/ https://www.ncbi.nlm.nih.gov/pubmed/33553300 http://dx.doi.org/10.21037/atm-20-4289

Ejemplares similares

From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
por: Chen, Qichen, et al.
Publicado: (2020)

Upgraded nomograms for the prediction of complications and survival in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by hepatic resection
por: Chen, Qichen, et al.
Publicado: (2021)

Preoperatively elevated RDW-SD and RDW-CV predict favorable survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Li, Xingchen, et al.
Publicado: (2021)

Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review
por: Wei, Zhewen, et al.
Publicado: (2022)

Preoperative D-dimer and Gamma-Glutamyltranspeptidase Predict Major Complications and Survival in Colorectal Liver Metastases Patients After Resection()
por: Chen, Qichen, et al.
Publicado: (2019)

Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastases
por: Li, Yuan, et al.
Publicado: (2016)

The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Chen, Qichen, et al.
Publicado: (2020)

A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
por: Li, Xingchen, et al.
Publicado: (2021)

Impact of Postoperative Infectious Complications on Long-Term Outcomes for Patients Undergoing Simultaneous Resection for Colorectal Cancer Liver Metastases: A Propensity Score Matching Analysis
por: Chen, Qichen, et al.
Publicado: (2022)

An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study
por: Deng, Yiqiao, et al.
Publicado: (2023)

Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection
por: Wang, Yikai, et al.
Publicado: (2023)

Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy
por: Chen, Qichen, et al.
Publicado: (2022)

Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods
por: Chen, Qichen, et al.
Publicado: (2021)

Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases
por: Guo, Jingfei, et al.
Publicado: (2016)

Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People’s Republic of China
por: Li, Cong, et al.
Publicado: (2014)

Should surgery be conducted for small nonfunctioning pancreatic neuroendocrine tumors: a systematic review
por: Guo, Jingfei, et al.
Publicado: (2017)

The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection
por: Wei, Zhewen, et al.
Publicado: (2021)

Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy
por: Luo, Zhiwen, et al.
Publicado: (2021)

Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma and Comparison with Gallbladder Adenocarcinoma Using a Propensity Score Matching
por: Yan, Shida, et al.
Publicado: (2020)

CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
por: Li, Yuan, et al.
Publicado: (2016)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Recent advances in the ARID family: focusing on roles in human cancer
por: Lin, Chen, et al.
Publicado: (2014)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma
por: Li, Cong, et al.
Publicado: (2014)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

ARID2: A new tumor suppressor gene in hepatocellular carcinoma
por: Zhao, Hong, et al.
Publicado: (2011)

Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validation
por: Chen, Qichen, et al.
Publicado: (2023)

Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection
por: Sun, Yongkun, et al.
Publicado: (2017)

Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
por: Cheng, Daoan, et al.
Publicado: (2023)

Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma
por: Shen, Dijian, et al.
Publicado: (2021)

TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection
por: Peng, Jianhong, et al.
Publicado: (2019)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
por: Perrone, Anna Myriam, et al.
Publicado: (2023)

The Impact of Preoperative Inflammatory Markers on the Prognosis of Patients Undergoing Surgical Resection of Pulmonary Oligometastases
por: Londero, Francesco, et al.
Publicado: (2020)

Two vs three cycles of neoadjuvant sintilimab plus chemotherapy for resectable non-small-cell lung cancer: neoSCORE trial
por: Shao, Miner, et al.
Publicado: (2023)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7fdbjlod14pptuab6occlqqj0v